VEGF attenuates development from cardiac hypertrophy to heart failure after aortic stenosis through mitochondrial mediated apoptosis and cardiomyocyte proliferation

Journal of Cardiothoracic Surgery

Volumn 6, Issue 1, 2011, Pages

  Xu, Xiao H ^a   Xu, Jing ^a   Xue, Lei ^a   Cao, Hai L ^a   Liu, Xiang ^a   Chen, Yi J ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADENOVIRUS; ANIMAL; AORTA VALVE STENOSIS; APOPTOSIS; ARTICLE; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; GENE VECTOR; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MITOCHONDRION; HEART MUSCLE CELL; MALE; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREOPERATIVE CARE; RANDOMIZATION;

ADENOVIRIDAE; ANIMALS; AORTIC VALVE STENOSIS; APOPTOSIS; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; PREOPERATIVE CARE; RANDOM ALLOCATION; VASCULAR ENDOTHELIAL GROWTH FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79955115054     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-6-54     Document Type: Article

References (21)

1. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, Barnes ME, Tajik AJ. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005, 111:3290-3295. 10.1161/CIRCULATIONAHA.104.495903, 15956131.
2. Grimard BH, Larson JM. Aortic stenosis: diagnosis and treatment. Am Fam Physician 2008, 78:717-724.
3. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodeling. Lancet 2006, 367:356-367. 10.1016/S0140-6736(06)68074-4, 16443044.
4. Zhou L, Ma W, Yang Z, Zhang F, Lu L, Ding Z, Ding B, Ha T, Gao X, Li C. VEGF165 and angiopoietin-1 decreased myocardium infact size through phosphatidylinsostitol-3 kinase and Bcl-2 pathways. Gene Ther 2005, 12:198-202.
5. Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 2006, 47:887-893. 10.1161/01.HYP.0000215207.54689.31, 16567591.
6. Zisa D, Shabbir A, Mastri M, Suzuki G, Lee T. Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells. Am J Physiol Regul Integr Comp Physiol 2009, 297:R1503-1515. 10.1152/ajpregu.00227.2009, 2777764, 19759338.
7. Njeim MT, Hajjar RJ. Gene therapy for heart failure. Arch Cardiovasc Dis 2010, 103:477-485. 10.1016/j.acvd.2010.04.004, 21074127.
8. Hu P, Zhang D, Swenson L, Chakrabarti G, Abel ED, Litwin SE. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 2003, 285:H1261-1269.
9. Gupta S, Knowlton AA. HSP60, Bax, apoptosis and the heart. J Cell Mol Med 2005, 9:51-58. 10.1111/j.1582-4934.2005.tb00336.x, 15784164.
10. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001, 280:C1358-1366.
11. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995, 1:1024-1028. 10.1038/nm1095-1024, 7489357.
12. Chan DC. Mitochondria: dynamic organelles in disease, aging and development. Cell 2006, 125:1241-1252. 10.1016/j.cell.2006.06.010, 16814712.
13. Chan DC. Dissecting mitochondrial fusion. Dev Cell 2006, 11:592-594. 10.1016/j.devcel.2006.10.009, 17084350.
14. Chen L, Gong Q, Stice JP, Knowlton AA. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc Res 2009, 84:91-99. 10.1093/cvr/cvp181, 2741347, 19493956.
15. Lee Y, Jeong S, Karbowski M, Smith CL, Youle RJ. Roles of mammalian mitochondrial fission and fusion mediators Fis1, Drp1 and OPA1 in apoptosis. Mol Biol Cell 2004, 15:5001-5011. 10.1091/mbc.E04-04-0294, 524759, 15356267.
16. Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, Kurth MJ, Shaw JT, Hinshaw JE, Green DR, Nunnari J. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 2008, 14:193-204. 10.1016/j.devcel.2007.11.019, 2267902, 18267088.
17. Hilfiker-Kleiner D, Landmesser U, Drexler H. Molecular mechanisms in heart failure: focus on cardiac hypertrophy, inflammation, angiogenesis, and apoptosis. J Am Coll Cardiol 2006, 48:A56-66.
18. Dimmeler S, Zeiher AM. Akt takes center stage in angiogenesis signaling. Cric Res 2000, 86:4-5.
19. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 2001, 26:657-664. 10.1016/S0968-0004(01)01958-2, 11701324.
20. Lim SY, Kim YS, Ahn Y, Jeong MH, Hong MH, Joo SY, Nam KI, Cho JG, Kang PM, Park JC. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 2006, 70:530-542. 10.1016/j.cardiores.2006.02.016, 16563361.
21. Liu X, Chen Y, Zhang F, Chen L, Ha T, Gao X, Li C. Synergistically therapeutic effects of VEGF165 and angiopoietin-1 on ischemic rat myocardium. Scand Cardiovasc J 2007, 41:95-101. 10.1080/14017430701197593, 17454834.